Bucillamine Study of Holding Remission After Infliximab Dose-off

Clinical trial NCT00716248 · UNKNOWN

Trial details

NCT number: NCT00716248
Sponsor: Saitama Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2007-01-01
Primary completion: 2011-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.